RESEARCH TRIANGLE PARK, N.C. (Dec. 12, 2011) – At an interactive session held during the American Seed Trade Association (ASTA) Seed Expo in Chicago, Bayer CropScience outlined the growing weed resistance crisis and its commitment to delivering sustainable solutions from seed to shelf through its innovative products Ignite® herbicide and LibertyLink® trait, the strength of its traits platform and ongoing research.
“With this environment we‘re in, there’s really no new herbicide mode of action on the horizon,“ said Dr. Larry Steckel, University of Tennessee and presenter at session hosted by Bayer CropScience, “These traits are going to play an integral part on how we’re going to manage weeds for the foreseeable future.“
As an independent and academic weed specialist, Dr. Steckel addressed the session outlining the growing weed resistance crisis.
Long committed to creating innovative technologies that protect and improve crops to help farmers achieve high quality yields, Bayer CropScience, also announced that it is doubling its investment to 3.5 billion euros toward bioscience research and development, germplasm, technologies and infrastructure to accelerate breeding advancements and trait development by 2015. Bayer CropScience also outlined how Ignite herbicide in a LibertyLink program provides the most reliable weed management solution today and provided insight into its research and development across seeds, traits and crop protection.
“Bayer CropScience is on the leading edge of offering solutions to agriculture’s biggest challenges with our leading position in the weed and insect management sector and our strong trait platform in corn and soybeans,” said Christophe Dumont, Global Head of Soybean and Corn, Bayer CropScience.
As part of the interactive session, seed company owners and representatives as well as other strategic partners participated in several live polls aimed at gauging their awareness of the magnitude of the weed resistance crisis and Bayer CropScience’s broad platform of seeds, traits and crop protection products.
- 80% of session attendees believe weed resistance is a significant problem in the Midwest.
- 66% of session attendees are convinced that Bayer CropScience will be a significant trait provider for soybeans in the future.
- 92% of session attendees believe LibertyLink and Ignite are more reliable in controlling weeds for
their customers than glyphosate.
For additonal information and background on weed resistance issues please visit Bayer CropScience’s YouTube channel, Flickr photos and Twitter handle. To learn more about Bayer CropScience, visit www.bayercropscience.us or contact your local sales representative for product information.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
Bayer CropScience Media Hotline, 1-877-879-6162, or
External Communications Lead
Tel: (919) 549-2030
Tel: (404) 995-4536
Find more information at www.bayercropscience.us.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.